An analysis of expression levels identified a positive correlation between SRC-1 and VEGFC levels in the thyroid cancer tissues, and showed that SRC-1 levels were positively associated with VEGFC expression in the tumors (r2 = 0.6756; 95% CI: 0.4536–0.8187) (Figure 1C). Here, NCOA1 is linked to thyroid gland carcinoma.